Acta Scientific Microbiology (ISSN: 2581-3226)

Research Article Volume 3 Issue 1

Immunological Profile of TB/HIV Co-Infected Patients Attending ADEPR Nyamata Hospital in Rwanda

Gisele Nyambere and Francois Niyongabo Niyonzima*

Department of Department of Biomedical Laboratory Sciences, Faculty of Applied Fundamental Sciences, INES-Ruhengeri, Rwanda

*Corresponding Author: Francois Niyongabo Niyonzima, Department of Department of Biomedical Laboratory Sciences, Faculty of Applied Fundamental Sciences, INES-Ruhengeri, Rwanda.

Received: October 17, 2019; Published: December 03, 2019



  Tuberculosis is an important disease that attacks mainly people from low income countries. One third of the population having HIV in Sub-Saharan African countries are also having TB. Investigating the prevalence and immunological profile of TB in patients having HIV is important step in discovering drugs and setting preventive measures. The present study aimed to estimate the CD4 cell levels and viral load in TB and HIV co-infected patients and to identify the prevalence of tuberculosis and HIV co-infected patients attending ADEPR Nyamata Hospital: It was a cross sectional study and was carried out on 85 HIV positive patients where18 patients were TB/HIV co-infected. Study participants were followed during 4 months of HAART initiation. This was based on the laboratory results of CD4 count from FACS count machine, and viral load results from AmpliPrep/COBAS® TaqMan® machine. Data were analysed with SPSS and significance was considered when P < 0.05. Among the 18 TB/HIV co-infected patients, compared to the CD4 levels before the initiation of treatment, there was a decrease in CD4 cells count at the level of 50.0% with CD4 cells less than 175 cells/mm3 and those patients had a viral load level above 1000 copies/ml. Patients between 36 and 54 years showed a high frequency of co-infection at the level of 44.4%. After 4 months treatment, only 11.1% of co-infected patients achieved an undetectable viral load means less than 20 copies/ml and 55.6% of co-infected patients their CD4+ T cells were recovered up to 350 cells/mm3 after taking treatment. In all co-infected patients, CD4 cells augmentation and viral load decline were observed after 4 months on treatment. It is recommended to take care of co-infected patients. CD4 count and viral load have to be regularly checked among HAART patients at least for a period of less than 90 days.

Keywords: Tb/Hiv Co-Infected Patients; Nyamata Hospital; Immunological Profile; Highly Active Antiretroviral Treatment, Tuberculosis



  1. Pawlowski ME., et al. “Tuberculosis and human immunodeficiency virus co-infection”. PLOS Pathogens 8 (2012): e1002464.
  2. Giorgia S., et al. “Tuberculosis: Epidemiology and control”. Mediterranean Journal of Hematology and Infectious Diseases 6 (2014): e2014070.
  3. Mitku AA., et al. “Prevalence and associated factors of TB/HIV co-infection among HIV infected patients in Ethiopia”. African Journal of Health Sciences 16 (2016): 588-595.
  4. Ligidi T. Prevalence of Human Immunodeficiency Virus Infection and Immune Status in Newly Diagnosed Adult Tuberculosis Patients in Adama Hospital (2008).
  5. Ayieko SY. Epidemiology of Tuberculosis and Human Immunodeficiency Virus Co-Infection, Clinical Presentations and Impact on Immune - Haematological Parameters in Mombasa (2015).
  6. Salim SSA., et al. “HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response”. Lancet 374 (2009): 921-933.
  7. Kangabo L. Immunological Profile of Tuberculosis and HIV Co-Infected Patients Attending Ruhengeri Referal Hospital (2017).
  8. Mukasano MV. “Trend of Tuberculosis from 2012-2016 at Nemba Hospital”. INES Ruhengeri, dissertation (2017).
  9. Yonge SA., et al. “Human Immunodeficiency virus and immunological profiles among suspected tuberculosis cases in Mombasa County, Kenya”. Journal of Tuberculosis Research 4 (2016): 34-45.
  10. Askar AHO. Tuberculosis and HIV Co-infection in Two District of Somaliland (2008).
  11. Asfaw A., et al. “CD4 Cell count trends after commencement of antiretroviral therapy among HIV infected patients in Tigray, Northern Ethiopia. A retrospective cross sectional study”. Plos One 10 (2015): e0122583.
  12. Jourdain G., et al. “Switching HIV treatment in adults based on CD4 count versus viral load monitoring: A randomized, non- inferiority trial in Thailand”. PLoS Medicine 10 (2013): e1001494.
  13. Nyirihirwe OBS. Assessment of Immune Status and Viral Load Levels Among HIV Positive Patients Attending Ruhengeri Referral Hospital (2017).
  14. Mermin J., et al. “Utility of routine viral load, CD4 cell count, and clinical monitoring among adults with HIV receiving antiretroviral therapy in Uganda: Randomised trial”. Biomedical Journal 343 (2011): d6792.
  15. Teshome A., et al. Prevalence of Mycobacterium Tuberculosis and HIV Infections Among Patients Visiting Dil-Chora Referral Hospital, Dire Dawa Administrative Council, Eastern Ethiopia (2014).


Citation: Gisele Nyambere and Francois Niyongabo Niyonzima. “Immunological Profile of TB/HIV Co-Infected Patients Attending ADEPR Nyamata Hospital in Rwanda".Acta Scientific Microbiology 3.1 (2020): 02-05.


Acceptance rate30%
Acceptance to publication20-30 days

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is May 30, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US